Jeffrey D Lebensburger1, Inmaculada Aban2, Brandi Pernell1, Malgorzata Kasztan3, Daniel I Feig4, Lee M Hilliard1, David J Askenazi4. 1. Division of Pediatric Hematology Oncology, University of Alabama at Birmingham, Birmingham, Alabama. 2. Department of Biostatistics, University of Alabama at Birmingham, Birmingham, Alabama. 3. Division of Cardio-Renal Physiology and Medicine, University of Alabama at Birmingham, Birmingham, Alabama. 4. Division of Pediatric Nephrology, University of Alabama at Birmingham, Birmingham, Alabama.
Abstract
BACKGROUND: In patients with diabetes mellitus, hyperfiltration precedes the development of albuminuria. Pediatric sickle cell anemia (SCA) patients have a high prevalence of hyperfiltration and albuminuria during early childhood and adolescence. We tested the hypothesis that hyperfiltration precedes the development of albuminuria in a longitudinal pediatric SCA cohort. METHODS: We identified 91 participants with HbSS or SB0 thalassemia 5-21 years of age enrolled in a longitudinal sickle cell nephropathy cohort study who had a cystatin C measured during early childhood (4-10 years of age). Early hyperfiltration was defined as a mean eGFR >180 mL/min/1.73m2 using cystatin C obtained from 4 to 10 years of age. Persistent albuminuria was defined as an albumin to creatinine ratio > 30 mg/g on two of three untimed urine specimens. Time to event analysis estimated survival curves for participants with and without hyperfiltration using Kaplan-Meier curves and used logrank test for categorical variables to assess the association with time to development of the first episode persistent albuminuria. RESULTS: Persistent albuminuria occurred more often and at an earlier age in participants with early hyperfiltration compared to those without early hyperfiltration (log-rank, P = .004). Participants who developed albuminuria have a significant increase in their eGFR during childhood (P = .003) as compared to participants who have not yet progressed to albuminuria (P = .26). For every 1 g/dL increase in hemoglobin, the hazard ratio for developing persistent proteinuria decreased by 0.56 (95% CI: 0.3, 1.06, P = .07). CONCLUSION: Hyperfiltration precedes the development of persistent proteinuria in pediatric SCA patients. Intervention strategies should target lowering eGFR during early childhood.
BACKGROUND: In patients with diabetes mellitus, hyperfiltration precedes the development of albuminuria. Pediatric sickle cell anemia (SCA) patients have a high prevalence of hyperfiltration and albuminuria during early childhood and adolescence. We tested the hypothesis that hyperfiltration precedes the development of albuminuria in a longitudinal pediatric SCA cohort. METHODS: We identified 91 participants with HbSS or SB0 thalassemia 5-21 years of age enrolled in a longitudinal sickle cell nephropathy cohort study who had a cystatin C measured during early childhood (4-10 years of age). Early hyperfiltration was defined as a mean eGFR >180 mL/min/1.73m2 using cystatin C obtained from 4 to 10 years of age. Persistent albuminuria was defined as an albumin to creatinine ratio > 30 mg/g on two of three untimed urine specimens. Time to event analysis estimated survival curves for participants with and without hyperfiltration using Kaplan-Meier curves and used logrank test for categorical variables to assess the association with time to development of the first episode persistent albuminuria. RESULTS: Persistent albuminuria occurred more often and at an earlier age in participants with early hyperfiltration compared to those without early hyperfiltration (log-rank, P = .004). Participants who developed albuminuria have a significant increase in their eGFR during childhood (P = .003) as compared to participants who have not yet progressed to albuminuria (P = .26). For every 1 g/dL increase in hemoglobin, the hazard ratio for developing persistent proteinuria decreased by 0.56 (95% CI: 0.3, 1.06, P = .07). CONCLUSION: Hyperfiltration precedes the development of persistent proteinuria in pediatric SCApatients. Intervention strategies should target lowering eGFR during early childhood.
Authors: Marianne McPherson Yee; Shameem F Jabbar; Ifeyinwa Osunkwo; Lisa Clement; Peter A Lane; James R Eckman; Antonio Guasch Journal: Clin J Am Soc Nephrol Date: 2011-09-22 Impact factor: 8.237
Authors: Santosh L Saraf; Binal N Shah; Xu Zhang; Jin Han; Bamidele O Tayo; Taimur Abbasi; Adam Ostrower; Elizabeth Guzman; Robert E Molokie; Michel Gowhari; Johara Hassan; Shivi Jain; Richard S Cooper; Roberto F Machado; James P Lash; Victor R Gordeuk Journal: Haematologica Date: 2016-09-22 Impact factor: 9.941
Authors: Divya G Moodalbail; Bonita Falkner; Scott W Keith; Robert S Mathias; Carlos E Araya; Joshua J Zaritsky; Marie J Stuart Journal: J Am Soc Hypertens Date: 2018-05-05
Authors: Benjamin Vazquez; Binal Shah; Xu Zhang; James P Lash; Victor R Gordeuk; Santosh L Saraf Journal: Am J Hematol Date: 2014-08-27 Impact factor: 10.047
Authors: Beverly A Schaefer; Jonathan M Flanagan; Ofelia A Alvarez; Stephen C Nelson; Banu Aygun; Kerri A Nottage; Alex George; Carla W Roberts; Connie M Piccone; Thad A Howard; Barry R Davis; Russell E Ware Journal: PLoS One Date: 2016-10-06 Impact factor: 3.240
Authors: Ann T Farrell; Julie Panepinto; Ankit A Desai; Adetola A Kassim; Jeffrey Lebensburger; Mark C Walters; Daniel E Bauer; Rae M Blaylark; Donna M DiMichele; Mark T Gladwin; Nancy S Green; Kathryn Hassell; Gregory J Kato; Elizabeth S Klings; Donald B Kohn; Lakshmanan Krishnamurti; Jane Little; Julie Makani; Punam Malik; Patrick T McGann; Caterina Minniti; Claudia R Morris; Isaac Odame; Patricia Ann Oneal; Rosanna Setse; Poornima Sharma; Shalini Shenoy Journal: Blood Adv Date: 2019-12-10
Authors: Rima S Zahr; Juan Ding; Guolian Kang; Winfred C Wang; Jane S Hankins; Kenneth I Ataga; Jeffrey D Lebensburger; Jerlym S Porter Journal: J Pediatr Hematol Oncol Date: 2022-02-18 Impact factor: 1.170
Authors: Omar Niss; Adam Lane; Monika R Asnani; Marianne E Yee; Ashok Raj; Susan Creary; Courtney Fitzhugh; Prasad Bodas; Santosh L Saraf; Sharada Sarnaik; Prasad Devarajan; Punam Malik Journal: Blood Adv Date: 2020-04-14
Authors: Cristin D W Kaspar; Isidora Beach; Jennifer Newlin; India Sisler; Daniel Feig; Wally Smith Journal: Pediatr Nephrol Date: 2020-01-20 Impact factor: 3.714
Authors: Robert I Liem; Sophie Lanzkron; Thomas D Coates; Laura DeCastro; Ankit A Desai; Kenneth I Ataga; Robyn T Cohen; Johnson Haynes; Ifeyinwa Osunkwo; Jeffrey D Lebensburger; James P Lash; Theodore Wun; Madeleine Verhovsek; Elodie Ontala; Rae Blaylark; Fares Alahdab; Abdulrahman Katabi; Reem A Mustafa Journal: Blood Adv Date: 2019-12-10
Authors: Kenneth I Ataga; Victor R Gordeuk; Irene Agodoa; Jennifer A Colby; Kimberly Gittings; Isabel E Allen Journal: PLoS One Date: 2020-04-03 Impact factor: 3.240